Confidence: 90%
B0G2BLLX6S
View on Amazon →Decision summary
A middling option. It may be usable, but weaker formulation coherence makes better alternatives worth comparing.
Best for
Buyers comparing price and availability and okay with a middle-of-the-pack option.
Consider another option if
You want one of the best-absorbed options in this category.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
4.5/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
Berberine: high-bioavailability form declared (Berberine HCl). The main limitation is that ceylon-cinnamon: below clinically studied range.
Strengths
Weaknesses
Final verdict
A middling option. It may be usable, but weaker formulation coherence makes better alternatives worth comparing.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ Evidence is strong, but dose is below the optimal range
Solid but not a standout: Dose is directionally useful, but not a standout strength. The declared form supports strong absorption.
Scientific evidence
Lan et al. meta-analysis berberine and lipid profile
Journal of Ethnopharmacology • 2015
PMID: 26448206.0
Dong et al. meta-analysis berberine and glycemic control in type 2 diabetes
Metabolism • 2012
PMID: 22162995.0
⚠ Dose is below commonly used clinical ranges
This is a limiting factor: Dose is likely below clinically useful levels.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
⚠ Limited evidence exists, and dose is below effective threshold
This is a limiting factor: Dose is likely below clinically useful levels. The declared form is acceptable, but not among the best-absorbed options.
Scientific evidence
Fuangchan et al. meta-analysis bitter melon and type 2 diabetes
Journal of Ethnopharmacology • 2011
PMID: 23777923.0
Evidence inferred from established knowledge, not directly linked studies
Supports the formula, but not a major driver: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Ceylon Cinnamon dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Formula design looks less coherent than stronger alternatives
The formulation appears less focused than better-built options.
Bitter Melon dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Berberine supplements ranked with the same methodology, or keep exploring the database.
